These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 707294)
21. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566 [TBL] [Abstract][Full Text] [Related]
22. [Primary vascular form of pulmonary hypertension. A comprehensive comparison with a new therapeutic and resistance-computing technic]. Degenring FH Arch Kreislaufforsch; 1972 Sep; 67(3):277-301. PubMed ID: 4405194 [No Abstract] [Full Text] [Related]
23. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478 [TBL] [Abstract][Full Text] [Related]
24. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension. Weir EK; Rubin LJ; Ayres SM; Bergofsky EH; Brundage BH; Detre KM; Elliott CG; Fishman AP; Goldring RM; Groves BM Am Rev Respir Dis; 1989 Dec; 140(6):1623-30. PubMed ID: 2690706 [TBL] [Abstract][Full Text] [Related]
25. Isoproterenol in primary pulmonary hypertension. Pantano JA N Engl J Med; 1980 Apr; 302(16):919-20. PubMed ID: 7360180 [No Abstract] [Full Text] [Related]
26. Successful treatment of a patient with severe pulmonary hypertension due to perivalvular leakage at aortic and mitral positions after aortic and mitral valve replacement. Miura T; Nishida H; Kawai A; Maeda T; Kurosawa H; Koyanagi H Gen Thorac Cardiovasc Surg; 2008 Oct; 56(10):521-5. PubMed ID: 18854932 [TBL] [Abstract][Full Text] [Related]
27. Hemodynamic effects of exercise, catecholamine stimulation and tachycardia in mitral stenosis and sinus rhythm at comparable heart rates. Nakhjavan FK; Katz MR; Shedrovilzky H; Maranhao V; Goldberg H Am J Cardiol; 1969 May; 23(5):659-66. PubMed ID: 5771034 [No Abstract] [Full Text] [Related]
31. Primary pulmonary hypertension treated with oral phentolamine. Ruskin JN; Hutter AM Ann Intern Med; 1979 May; 90(5):772-4. PubMed ID: 434677 [TBL] [Abstract][Full Text] [Related]
32. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308 [TBL] [Abstract][Full Text] [Related]
33. The role of isoproterenol in pulmonary artery hypertension of unknown etiology (primary): short- and long-term evaluation. Lupi-Herrera E; Bialostozky D; Sobrino A Chest; 1981 Mar; 79(3):292-6. PubMed ID: 7471861 [TBL] [Abstract][Full Text] [Related]
34. Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. Girard C; Fargnoli JM; Godin-Ribuot D; Dutheil V; Maitrasse B; Girardet P; Arvieux CC J Heart Lung Transplant; 1996 Jul; 15(7):700-8. PubMed ID: 8820786 [TBL] [Abstract][Full Text] [Related]
35. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741 [TBL] [Abstract][Full Text] [Related]
36. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
37. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model. Hedelin P; Kylhammar D; Rådegran G Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419 [TBL] [Abstract][Full Text] [Related]
38. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease. Dantzker DR; Bower JS Am Rev Respir Dis; 1981 Aug; 124(2):129-31. PubMed ID: 6789732 [TBL] [Abstract][Full Text] [Related]
39. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478 [TBL] [Abstract][Full Text] [Related]
40. Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Jones K; Higenbottam T; Wallwork J Chest; 1989 Oct; 96(4):784-9. PubMed ID: 2507232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]